May 31 (SeeNews) - Bulgarian pharmaceuticals maker Sopharma [BUL:SFA] said its consolidated net profit after minority interest fell to 29.7 million levs ($16.4 million/15.2 million euro) in the first three months of 2024 from 32.3 million levs in the same period last year.